Medicare to limit coverage for Aduhelm, an Alzheimer’s drug with questionable benefits that triggered a jump in premiums

AP

WASHINGTON (AP) — Medicare to limit coverage for Aduhelm, an Alzheimer’s drug with questionable benefits that triggered a jump in premiums.

Categories: AP National News